MIT scientists created a new therapy using lipid nanoparticles to reduce neuroinflammation in Alzheimer's, showing potential in early tests on human cells and mice.

UMass Amherst study links household chemical exposure to lower pregnancy chances, with phthalates in items like makeup and vinyl flooring prolonging time to conceive.

An older adult died in a Raynham fire, with officials highlighting the absence of working smoke alarms at the scene. Investigations point to an accidental origin, emphasizing the need for fire safety.

MIT scientists developed a machine-learning model to rapidly predict chemical reaction transition states, a task previously difficult and time-consuming.

MIT researchers' study on deep neural networks shows a strong similarity to human auditory processing, which could improve hearing aids and other auditory devices.

Two women from New York were charged with stealing over 4,600 gift cards from a Braintree pharmacy, believed to be part of a larger scam ring that drains card values quickly.

A gene-editing trial targeting high cholesterol showed promise, reducing LDL levels by up to 55%, but the safety and long-term effects remain concerns. The trial had a small sample size and did not have a control group.

MIT mathematicians replicated quantum behavior in a macro-scale experiment with silicone oil droplets, offering new insights into quantum mechanics with potential technological applications.

Boston University's CTE Center is examining the brain of Robert Card, the suspected Lewiston shooter, to investigate potential links between his military service and mental health issues.

MIT researchers have created a cost-effective, 3D-printed microfluidic device with self-heating capability, potentially transforming disease detection.

MIT researchers have developed a new method for incorporating two-dimensional materials into electronics without damaging them, promising advancements in high-performance devices.

MIT engineers have created a robotic replica of the right ventricle of the human heart, aiding in the study of heart disorders and the testing of cardiac devices.

The FDA approves a new gene therapy, Casgevy, for sickle cell disease in patients aged 12 and older, along with a second treatment, Lyfgenia, offering new options for this life-threatening disorder.